The American Society of Anesthesiologists (ASA) today announced Medtronic plc (NYSE:MDT), a global leader in medical technology, as an ASA Industry Supporter for the seventh year, supporting the work of the Society and physician anesthesiologists to improve patient safety and brain health during and following surgical procedures.
COLUMBUS, Ohio – The team of neurologists and neurosurgeons at The Ohio State University Wexner Medical Center and its Neurological Institute are among the first in the nation to implant a new deep-brain stimulation (DBS) device that will help improve the quality of life of patients with Parkinson’s disease.
Medtronic Joins American Spine Registry as Sponsor
Patients with type 1 diabetes who use Medtronic’s MiniMedTM 670G insulin pump system are able to maintain blood glucose levels in the targeted range over 71% of the time, according to a study that analyzed some 6 million days of real-world data. Results of the industry-supported study were accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and will be published in a special supplemental issue of the Journal of the Endocrine Society.